{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:26:13Z","timestamp":1773419173515,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T00:00:00Z","timestamp":1331078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Context\u2002<\/jats:bold> Primary aldosteronism (PA) is mainly caused by aldosterone\u2010producing adenoma and idiopathic bilateral adrenal hyperplasia (IHA). Recently, spontaneous resolution of IHA has been described.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> We aimed to determine the frequency of spontaneous remission of PA during long\u2010term treatment with mineralocorticoid receptor (MR) antagonists.<\/jats:p><jats:p><jats:bold>Design, setting and patients\u2002<\/jats:bold> Thirty\u2010seven patients of the Munich PA registry with IHA treated by MR antagonists were investigated. The patients were identified retrospectively by chart review and prospectively assessed by clinical and biochemical means.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> Complete remission of IHA was defined as normal aldosterone to renin ratio (ARR), normal suppression test and normalization of hypokalaemia in the presence of normal blood pressure. Partial remission was defined as normalization of normal ARR, normal suppression test and normalization of hypokalaemia in the presence of persistent hypertension.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The mean period of MR antagonist treatment was 5\u00b78\u2003\u00b1\u20030\u00b77\u2003years in the patients. We identified two of 37 (5\u00b74%) patients with spontaneous remission: one with complete remission and one with partial remission.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Remission of IHA in PA may occur in some patients after long\u2010term mineralocorticoid antagonist treatment.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2011.04243.x","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T17:50:59Z","timestamp":1317318659000},"page":"473-477","source":"Crossref","is-referenced-by-count":28,"title":["Spontaneous remission of idiopathic aldosteronism after long\u2010term treatment with spironolactone: results from the German Conn\u2019s Registry"],"prefix":"10.1111","volume":"76","author":[{"given":"Evelyn","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Degenhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,7]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031337"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh112"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000040261.30455.B6"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60834-X"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0104"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.4.509"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.096925"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345379"},{"key":"e_1_2_9_11_2","first-page":"305","article-title":"The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry","volume":"106","author":"Schirpenbach C.","year":"2009","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-011-9163-7"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2803"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(94)00013-3"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346520"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(84)90407-2"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-4-734"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(77)90026-9"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00313028309083505"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2116"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1247545"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2008.04882.x"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-010-0664-8"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.391"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.202"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6018.1125-a"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90474-X"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-5-1009"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1851"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04243.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2011.04243.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:36:56Z","timestamp":1698781016000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04243.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1111\/j.1365-2265.2011.04243.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04243.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,7]]}}}